Credit Suisse’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-486,872
| Closed | -$23.4M | – | 3578 |
|
|
2020
Q1 | $23.4M | Buy |
486,872
+131,782
| +37% | +$6.33M | 0.02% | 601 |
|
|
2019
Q4 | $16.7M | Buy |
355,090
+310,704
| +700% | +$14.6M | 0.01% | 852 |
|
|
2019
Q3 | $1.05M | Buy |
44,386
+8,293
| +23% | +$196K | ﹤0.01% | 2366 |
|
|
2019
Q2 | $1.08M | Sell |
36,093
-18,634
| -34% | -$560K | ﹤0.01% | 2310 |
|
|
2019
Q1 | $1.23M | Buy |
+54,727
| New | +$1.23M | ﹤0.01% | 2214 |
|
|
2018
Q2 | – | Sell |
-294,681
| Closed | -$1.57M | – | 3640 |
|
|
2018
Q1 | $1.57M | Buy |
+294,681
| New | +$1.57M | ﹤0.01% | 2247 |
|
|
2017
Q4 | – | Sell |
-10,151
| Closed | -$148K | – | 3710 |
|
|
2017
Q3 | $148K | Buy |
+10,151
| New | +$148K | ﹤0.01% | 3522 |
|